MAIA Biotechnology, Inc.: director Louie Ngar Yee received 39,634 shares

What happened

• Louie Ngar Yee, a director, received a grant of 39,634 derivative shares (stock options) on Sep 30, 2026. The filing reports an acquisition price of $0 and classifies the transaction as a derivative award.

Key details

• Transaction date and price: Sep 30, 2026; $0.00 per share.
• Transaction type/code: Award/grant (A); derivative (stock options).
• Shares owned after the transaction: not reported in the filing.
• Footnote: The options were granted under MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, vest 100% on the date of grant and are exercisable beginning as of that date.
• Filing date: Oct 2, 2026.

Why it may matter

• This was a grant of stock options that vested 100% on the grant date and are immediately exercisable per the footnote.
• This filing does not show why the insider traded or why the company acted.